NURIX THERAPEUTICS INC's ticker is NRIX and the CUSIP is 67080M103. A total of 119 filers reported holding NURIX THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,226,997 | -21.3% | 283,333 | 0.0% | 0.65% | -18.9% |
| Q2 2023 | $2,830,497 | +12.5% | 283,333 | 0.0% | 0.80% | +6.4% |
| Q1 2023 | $2,515,997 | -19.1% | 283,333 | 0.0% | 0.75% | -24.2% |
| Q4 2022 | $3,110,996 | -15.7% | 283,333 | 0.0% | 0.99% | -21.0% |
| Q3 2022 | $3,692,000 | +2.8% | 283,333 | 0.0% | 1.26% | +6.2% |
| Q2 2022 | $3,590,000 | -9.5% | 283,333 | 0.0% | 1.18% | +3.5% |
| Q1 2022 | $3,969,000 | -51.6% | 283,333 | 0.0% | 1.14% | -50.6% |
| Q4 2021 | $8,202,000 | -3.4% | 283,333 | 0.0% | 2.32% | -11.6% |
| Q3 2021 | $8,489,000 | -3.6% | 283,333 | 0.0% | 2.62% | -16.2% |
| Q1 2021 | $8,809,000 | – | 283,333 | – | 3.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 1,822,883 | $14,327,860 | 1.60% |
| DAFNA Capital Management LLC | 556,695 | $4,375,623 | 1.36% |
| Redmile Group, LLC | 2,848,827 | $22,391,780 | 1.06% |
| Deep Track Capital, LP | 2,997,830 | $23,562,944 | 0.91% |
| WestHill Financial Advisors, Inc. | 283,333 | $2,226,997 | 0.65% |
| Soleus Capital Management, L.P. | 814,000 | $6,398,040 | 0.59% |
| Affinity Asset Advisors, LLC | 250,000 | $1,965,000 | 0.55% |
| Boxer Capital, LLC | 1,224,892 | $9,627,651 | 0.51% |
| AtonRa Partners | 24,227 | $190,424 | 0.40% |
| WASATCH ADVISORS LP | 3,564,616 | $28,017,882 | 0.18% |